^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Pancreatic Adenocarcinoma |
| Regimen: | FOLFIRI ( + irinotecan + leucovorin calcium) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
05/04/2023
Excerpt:
Pancreatic Adenocarcinoma….PRINCIPLES OF SYSTEMIC THERAPY….Useful in Certain Circumstances...If previous first-line FOLFIRINOX: 5-FU + leucovorin + irinotecan (FOLFIRI)
